Home
>
National Drug Code (NDC)
>
Nexavar
Nexavar - 50419-488-58 - (sorafenib)
Drug Information of Nexavar
| Product NDC: | 50419-488 |
| Proprietary Name: | Nexavar |
| Non Proprietary Name: | sorafenib |
| Active Ingredient(s): | 200 mg/1 & nbsp; sorafenib |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Nexavar
| Product NDC: | 50419-488 |
| Labeler Name: | Bayer HealthCare Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021923 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20051220 |
Package Information of Nexavar
| Package NDC: | 50419-488-58 |
| Package Description: | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-488-58) |
NDC Information of Nexavar
| NDC Code | 50419-488-58 |
| Proprietary Name | Nexavar |
| Package Description | 120 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (50419-488-58) |
| Product NDC | 50419-488 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | sorafenib |
| Dosage Form Name | TABLET, FILM COATED |
| Route Name | ORAL |
| Start Marketing Date | 20051220 |
| Marketing Category Name | NDA |
| Labeler Name | Bayer HealthCare Pharmaceuticals Inc. |
| Substance Name | SORAFENIB |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Kinase Inhibitor [EPC],Protein Kinase Inhibitors [MoA] |
